How to Choose the Right Liver Cancer Specialist in Shanghai | CMCS Guide

Finding the Right Liver Cancer Specialist in Shanghai — A Patient's Guide

Liver cancer treatment is one of the most multidisciplinary fields in oncology. No single specialist manages liver cancer alone — optimal outcomes depend on the coordinated expertise of hepatobiliary surgeons, liver transplant surgeons, interventional oncologists, medical oncologists, and integrative medicine specialists. Shanghai is home to some of the world's most accomplished liver cancer specialists across all of these disciplines.

The key question for international patients is: which specialist is right for my specific situation? This guide helps you match your clinical needs to the most appropriate expert at Shanghai's leading hospitals, all accessible through China Medical Concierge Shanghai (CMCS).

If You Have Early-Stage, Resectable Liver Cancer

For patients with early-stage HCC who are candidates for curative surgery, the priority is accessing Shanghai's highest-volume, most experienced hepatobiliary surgical teams. Liver cancer surgery outcomes are strongly correlated with surgical volume and team expertise.

• Academician Fan Jia (樊嘉) & Prof. Zhou Jian (周俣) — Zhongshan Hospital, Fudan University: China's most internationally recognized liver cancer surgical program. Their team has set global benchmarks for resection and transplantation outcomes, pioneered the Hangzhou Criteria for expanded transplant eligibility, and published landmark research in Nature Medicine and Journal of Clinical Oncology. For patients seeking the absolute pinnacle of liver cancer surgical expertise in China, this is the team.
• Dr. Sun Yunfan (孙云帆) — Zhongshan Hospital, Fudan University: Core member of the Fan Jia team, Shanghai Silver Snake Award First Prize winner, with 2,000+ hepatobiliary surgeries and important research discoveries in liver cancer metastasis and recurrence mechanisms.
• Dr. Wang Zhengxin (王正昕) — Huashan Hospital, Fudan University: Director of the Liver Transplant Center with 3,100+ personal liver transplants. His team ranked #1 in China for adult liver transplant volume in 2023. Deep expertise in HCC transplantation and post-transplant recurrence prevention.
• Dr. Hang Hualian (杭化莲) — Shanghai First People's Hospital: Director of Hepatobiliary Surgery, specializing in precision liver resection using 3D volumetry, ICG fluorescence guidance, and minimally invasive techniques, plus liver transplantation.
• Dr. Zhu Jianjun (朱建军) — Renji Hospital: Shanghai Rising Star scientist proficient in the full spectrum of liver transplant techniques — living donor (LDLT), orthotopic (OLT), and split liver transplantation — plus liver tumor resection.

If You Have Intermediate or Advanced Liver Cancer (Not Immediately Operable)

For patients with intermediate or advanced HCC who are not immediate surgical candidates, interventional oncology is the cornerstone of treatment. Shanghai's interventional oncologists offer the full spectrum of locoregional therapies, often combined with systemic targeted therapy and immunotherapy.

• Dr. Xu Aimin (徐爱民) — Renji Hospital: Chief Physician with 35,000+ tumor interventional procedures — China's highest individual volume. The go-to expert for TACE, ablation, HAIC, and Y-90 for intermediate and advanced HCC.
• Dr. Luo Jianjun (罗剑钒) — Zhongshan Hospital: Director of Vascular Interventional Subspecialty, specializing in liver cancer interventional therapy and portal hypertension complications (TIPS, BRTO) — particularly valuable for patients with cirrhosis and variceal bleeding alongside HCC.
• Dr. Shi Yaoping (史瑶平) — Renji Hospital: Deputy Director with strong translational research background, specializing in individualized combination interventional protocols — TACE, ablation, and HAIC in evidence-based sequences.
• Dr. Wang Tao (王涛) — Renji Hospital: Specialist in liver cancer with portal vein tumor thrombus (PVTT) — one of the most challenging HCC presentations. If you have been told your cancer has invaded the portal vein, Dr. Wang's expertise in HAIC combinations and surgical thrombectomy offers options that many centers cannot provide.

If You Want Integrative TCM Support Alongside Western Treatment

Traditional Chinese Medicine has an evidence-based role in liver cancer management — reducing treatment side effects, protecting liver function, preventing recurrence, and improving quality of life. Shanghai's Changhai Hospital TCM Oncology Department is the national authority in this field.

• Prof. Ling Changquan (凌昌全) — Changhai Hospital: National Famous TCM Physician and National Distinguished Young Scholar. Creator of the "Cancer Toxin" theory of liver cancer. His integrative protocol is incorporated into China's National Primary Liver Cancer Diagnosis and Treatment Guidelines.
• Dr. Zhai Xiaofeng (翡笑枫) — Changhai Hospital: Director of TCM Oncology and lead author of the national Guidelines for Integrative TCM-Western Medicine Diagnosis and Treatment of Primary Liver Cancer. Specializes in HCC and all hepatobiliary malignancies including cholangiocarcinoma and gallbladder cancer.

Quick Reference: Specialist Matching Guide

Important Notes for International Patients

Liver cancer treatment decisions are complex and should ideally involve a multidisciplinary team (MDT) discussion. When you come to Shanghai for a liver cancer consultation, bring:

• All previous imaging files in DICOM format (CT, MRI, PET-CT) — on a USB drive or CD
• Pathology reports and biopsy results if available
• Tumor marker results (AFP, AFP-L3, DCP/PIVKA-II, CA19-9)
• Liver function tests (Child-Pugh score, MELD score if available)
• Viral hepatitis status (HBV DNA, HCV RNA)
• All previous treatment records (surgery, TACE, ablation, systemic therapy)

Specialist clinic schedules may change. Before traveling to Shanghai, please confirm appointment availability through the hospital's official app or by contacting CMCS directly.

Contact CMCS

📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com